Differential effects of dosing regimen on the safety and efficacy of dasatinib: retrospective exposure-response analysis of a Phase III study

Differential effects of dosing regimen on the safety and efficacy of dasatinib: retrospective exposure-response analysis of a Phase III study

Item
http://www.wikidata.org/entity/Q36933601
Efficacy and safety of dasatinib versus imatinib in the East Asian subpopulation of the DASISION trial of newly diagnosed chronic myeloid leukemia in chronic phase.The use of betaine HCl to enhance dasatinib absorption in healthy volunteers with rabeprazole-induced hypochlorhydria.European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013.Philadelphia chromosome-positive acute lymphoblastic leukemia with extramedullary and meningeal relapse after allogeneic hematopoietic stem cell transplantation that was successfully treated with dasatinib.The development of dasatinib as a treatment for chronic myeloid leukemia (CML): from initial studies to application in newly diagnosed patients.Practical Recommendations for Therapeutic Drug Monitoring of Kinase Inhibitors in Oncology.Therapeutic drug monitoring and tyrosine kinase inhibitors.The Efficacy of Reduced-dose Dasatinib as a Subsequent Therapy in Patients with Chronic Myeloid Leukemia in the Chronic Phase: The LD-CML Study of the Kanto CML Study Group.Dasatinib dose management for the treatment of chronic myeloid leukemia.A validated UPLC-MS/MS method for simultaneous determination of imatinib, dasatinib and nilotinib in human plasma.Pretreatment evaluation of fluorescence resonance energy transfer-based drug sensitivity test for patients with chronic myelogenous leukemia treated with dasatinib.Association of Dasatinib With Progression-Free Survival Among Patients With Advanced Gastrointestinal Stromal Tumors Resistant to Imatinib.
P2860

Differential effects of dosing regimen on the safety and efficacy of dasatinib: retrospective exposure-response analysis of a Phase III study

Item
http://www.wikidata.org/entity/Q36933601
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Differential effects of dosing ...... analysis of a Phase III study
@en
type
label
Differential effects of dosing ...... analysis of a Phase III study
@en
prefLabel
Differential effects of dosing ...... analysis of a Phase III study
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P478
P50
P577
P698
P932
P356
P1433
P1476
Differential effects of dosing ...... analysis of a Phase III study
@en
P2093
P2860
P304
P31
P356
P407
P478
P50
P577
P698
P932